Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Synta Pharmaceuticals, Herman Miller, and Tower Semiconductor Jumped Today

By Dan Caplinger - Mar 20, 2014 at 8:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Thursday featured a solid rebound for the broad stock market on hopes of economic recovery, but these three stocks did much better than major market benchmarks. Find out more about what made these stocks soar.

After yesterday's surprise comments from Fed Chair Janet Yellen regarding the potential for interest rate hikes by next year, many investors weren't sure how stocks would react the morning after. But encouraging economic news from a rise in the Leading Economic Index pointed to a rebound in growth later this year, and stocks responded favorably. Some of the best performers on Thursday included Synta Pharmaceuticals (NASDAQ: SNTA), Herman Miller ( MLHR -1.74% ), and Tower Semiconductor ( TSEM -1.25% ).

Synta jumped 9.5% as the small drugmaker released encouraging study results for its ganetespib treatment for metastatic breast cancer. The good news came on the heels of last week's announcement that ganetespib had been chosen to take part in a breast-cancer trial sponsored by a third-party investigator. The drug has the potential to fight a number of different types of cancer, including ovarian and non-small-cell lung cancer, as well as multiple myeloma. With promising study results, investors will get more excited about Synta's prospects to play a key role in treating cancer patients.

Herman Miller climbed more than 9% after reporting strong earnings last night. Revenue for the maker of office furniture and accessories climbed almost 8% year over year, but the more encouraging news came from a 21% jump in order growth, which stretched across its various business lines and geographical areas it serves. Although some of the growth that Herman Miller saw came from its acquisition of Maharam, which bolstered its Specialty and Consumer segment's results, CEO Brian Walker also highlighted gains in order growth from the U.S. government and key international markets. If economic conditions do, in fact, improve, Herman Miller is in a great position to capitalize.

Tower Semiconductor gained just less than 9% as the tech company said this morning that it had come to an agreement with its bondholders to improve the strength of its finances. Although the corporate structure of Tower's various subsidiaries is complex, the essence of the deal is that various Tower entities will issue new convertible bonds due in late 2018 to refinance bonds due next year. The move will reduce net debt by $55 million and extend its overall maturity, ensuring that Tower will have the financing it needs to support its growth initiatives well into the future.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Herman Miller, Inc. Stock Quote
Herman Miller, Inc.
MLHR
$37.94 (-1.74%) $0.67
Tower Semiconductor Ltd. Stock Quote
Tower Semiconductor Ltd.
TSEM
$35.48 (-1.25%) $0.45

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
673%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.